Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAIN PC CONTROL: Semaglutide in Men With Prostate Cancer
NCT06908694Phase 4Active, not recruiting
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 2025
- Primary completion
- Oct 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity, sponsored by Hamilton Health Sciences. Started Jul 2025; status: active, not recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06908694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06908694.